Advertisement
Screener

LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number

2.8 / 5 stars · 68/120 Roast Me

LIGAND PHARMACEUTICALS INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number

LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 2.14 million shares as of 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-08-07

  • 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 2.14M shares.
  • 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 2.22M shares.
  • 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 2.00M shares.
  • 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 2.12M shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, NumberShare-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed
2026-06-302.14M shares
10-Q · filed 2026-08-07
2026-03-312.22M shares
10-Q · filed 2026-05-08
2025-12-312.00M shares
10-Q · filed 2026-08-07
2025-09-302.12M shares
10-Q · filed 2025-11-07
2025-06-302.45M shares
10-Q · filed 2025-08-08
2025-03-312.53M shares
10-Q · filed 2025-05-09
2024-12-312.23M shares
10-K · filed 2026-02-27
2024-09-302.54M shares
10-Q · filed 2024-11-08
2024-06-302.84M shares
10-Q · filed 2024-08-07
2024-03-312.91M shares
10-Q · filed 2024-05-08
2023-12-312.64M shares
10-K · filed 2026-02-27
2023-09-302.81M shares
10-Q · filed 2023-11-09
2022-12-312.99M shares
10-K · filed 2026-02-27
2022-10-312.99M shares
10-K · filed 2025-02-28
2021-12-312.20M shares
10-K · filed 2025-02-28
2020-12-312.56M shares
10-K · filed 2024-02-29
2019-12-311.96M shares
10-K · filed 2023-02-28
2018-12-311.74M shares
10-K · filed 2022-02-28
2018-06-301.90M shares
10-Q · filed 2018-08-08
2018-03-311.95M shares
10-Q · filed 2018-05-09
2017-12-311.88M shares
10-K · filed 2021-02-24
2017-09-301.83M shares
10-Q · filed 2017-11-09
2017-06-301.87M shares
10-Q · filed 2017-08-09
2017-03-311.91M shares
10-Q · filed 2017-05-09
2016-12-311.75M shares
10-K · filed 2018-03-01
2016-09-301.79M shares
10-Q · filed 2016-11-14
2016-06-301.84M shares
10-Q · filed 2016-11-14
2016-03-311.88M shares
10-Q · filed 2016-11-14
2015-12-311.68M shares
10-K · filed 2017-02-28
2015-09-301.71M shares
10-Q · filed 2015-11-09
2015-06-301.77M shares
10-Q · filed 2015-08-05
2015-03-312.00M shares
10-Q · filed 2015-05-11
2014-12-311.80M shares
10-K · filed 2016-11-14
1.75M shares
10-K · filed 2014-12-01
2014-09-301.80M shares
10-Q · filed 2014-10-31
2014-06-301.83M shares
10-Q · filed 2014-08-05
2014-03-311.83M shares
10-Q · filed 2014-05-07
2013-12-311.75M shares
10-K · filed 2015-02-23
2013-09-301.81M shares
10-Q · filed 2013-11-08
2013-06-301.91M shares
10-Q · filed 2013-08-01
2013-03-311.91M shares
10-Q · filed 2013-05-08
2012-12-311.63M shares
10-K/A · filed 2014-12-12
2012-09-301.71M shares
10-Q · filed 2012-11-14
2012-06-301.69M shares
10-Q/A · filed 2012-11-14
2011-12-311.15M shares
10-K/A · filed 2014-12-12
2010-12-31641.26K shares
10-K/A · filed 2014-12-12
2009-12-31668.45K shares
10-K · filed 2013-03-14